Please login to the form below
Torre Lazur McCann
Want to know which agency did which ad? Search using one of the options below.
Agency:
Torre Lazur McCann
Product:
Risperdal
Client:
Janssen-Cilag Ltd
Therapy area:
Central Nervous System
Agency:
Torre Lazur McCann
Product:
Safinamide
Client:
Merck Serono
Therapy area:
Central Nervous System
Agency:
Torre Lazur McCann
Product:
Kivexa
Client:
ViiV Healthcare
Therapy area:
Infections and Infestations
Agency:
Torre Lazur McCann
Product:
Kivexa
Client:
ViiV Healthcare
Therapy area:
Infections and Infestations
Agency:
Torre Lazur McCann
Product:
Charity Calendar 2010
Client:
Arthritis Research Campaign
Therapy area:
Corporate / Other
Featured jobs
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Account director
-
Competitive salary and bonus scheme
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Senior External Communications Lead
-
£Competitive Salary
-
Account Manager
-
£Competitive Salary
-
Scientific Director
-
£60000 - £85000 per annum, Benefits: Bonus, pension, subsidised gym and much more
-
Publications director
-
Competitive salary and bonus scheme
-
Account Director
-
£Competitive Salary
- Digital Associate Director - Medcomms
-
£65000 - £80000 per annum
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
-
Experienced medical editor
-
Competitive salary and bonus scheme
-
Account Manager (PR)
-
Great Benefits
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
- Account Director, Healthcare Communications
-
Salary TBC
-
Account Director, Medical Education
-
Salary TBC
Subscribe to our email news alerts
- Merck’s Ebola vaccine wins approval in four African countries
- US backs Sanofi’s ‘fast-track’ coronavirus vaccine
- Bayer shares dip as Novartis gets EU okay for Beovu in wet AMD
- Bayer shares dip as Novartis gets EU okay for Beovu in wet AMD
- Novo Nordisk awakens its ‘Sleeping Beauty’
- Researchers discover new antibiotic using AI
- As new coronavirus outbreaks emerge, fears of a global pandemic escalate
- Introducing Nucleus POLAR™, a state-of-the-art external expert search engine and engagement management tool
- BMS scores first oesophageal cancer nod for Opdivo in Japan
- Esperion gets FDA thumbs up for cholesterol drug Nexletol
- Lundbeck gets US approval for migraine drug at heart of Alder takeover
- BRIC markets
PMHub
IGNIFI
We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...
Quick links
Infographics
